Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists (scientific article)

cites work (P2860)

Q35825847	4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor.
Q39004681	7TM Domain Structure of Adhesion GPCRs
Q45228067	7×7 RMSD matrix: A new method for quantitative comparison of the transmembrane domain structures in the G-protein coupled receptors
Q57794644	A Chimeric GPCR Model Mimicking the Ligand Binding Site of the Human Y1 Receptor Studied by NMR Spectroscopy
Q28817975	A G Protein-Coupled Receptor Dimerization Interface in Human Cone Opsins
Q27681101	A Model of GAG/MIP-2/CXCR2 Interfaces and Its Functional Effects
Q35624221	A Novel Screening Approach for Optimal and Functional Fusion of T4 Lysozyme in GPCRs
Q36092130	A Strategy Combining Differential Low-Throughput Screening and Virtual Screening (DLS-VS) Accelerating the Discovery of new Modulators for the Orphan GPR34 Receptor.
Q47348737	A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
Q38008721	A beginner's guide to chemokines
Q39341462	A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer.
Q35498775	A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)
Q44612728	A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity
Q28249697	A functional selectivity mechanism at the serotonin-2A GPCR involves ligand-dependent conformations of intracellular loop 2
Q54238056	A guide to chemokines and their receptors.
Q42182479	A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.
Q41925842	A membrane-proximal, C-terminal α-helix is required for plasma membrane localization and function of the G Protein-coupled receptor (GPCR) TGR5
Q34322789	A minimal ligand binding pocket within a network of correlated mutations identified by multiple sequence and structural analysis of G protein coupled receptors
Q98159123	A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
Q35305286	A new crystal structure fragment-based pharmacophore method for G protein-coupled receptors
Q39880678	A new era of GPCR structural and chemical biology
Q34089069	A novel CXCR4-selective high-affinity fluorescent probe and its application in competitive binding assays
Q33880430	A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transfer
Q36334029	A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry
Q35078604	A rapid and efficient way to obtain modified chemokines for functional and biophysical studies
Q90281782	A receptor for the complement regulator factor H increases transmission of trypanosomes to tsetse flies
Q30654651	A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.
Q39411714	A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design
Q37118542	A synthetic bivalent ligand of CXCR4 inhibits HIV infection
Q38827863	A systematic approach to prioritize drug targets using machine learning, a molecular descriptor-based classification model, and high-throughput screening of plant derived molecules: a case study in oral cancer.
Q46439057	ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration.
Q48045458	Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
Q34251407	Action of molecular switches in GPCRs--theoretical and experimental studies.
Q96132105	Advances in therapeutic peptides targeting G protein-coupled receptors
Q36213478	Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1
Q24303747	Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Q41308798	Agonist-induced dimer dissociation as a macromolecular step in G protein-coupled receptor signaling
Q42738899	Agonists for the Chemokine Receptor CXCR4.
Q35860717	Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics
Q38847270	Allosteric Modulators of the Class A G Protein Coupled Receptors
Q38795713	Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach
Q37952607	Allosteric mechanisms of G protein-Coupled Receptor signaling: a structural perspective
Q35312348	Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).
Q53082766	Allosteric modulation as a unifying mechanism for receptor function and regulation.
Q30448534	Allosteric modulation of metabotropic glutamate receptors
Q35952381	Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery
Q34508675	Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Q40710135	Alpha-bulges in G protein-coupled receptors
Q35274763	Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages
Q37662779	Amino acid conservation and interactions in rhodopsin: probing receptor activation by NMR spectroscopy
Q90420034	An Agonist of the CXCR4 Receptor Strongly Promotes Regeneration of Degenerated Motor Axon Terminals
Q38850243	An Ensemble-Based Protocol for the Computational Prediction of Helix-Helix Interactions in G Protein-Coupled Receptors using Coarse-Grained Molecular Dynamics
Q35019647	An analysis of oligomerization interfaces in transmembrane proteins.
Q58097965	An efficient nanolitre-volume multi-channel device for highly viscous materials used in membrane protein crystallization
Q41913411	An expression and purification system for the biosynthesis of adenosine receptor peptides for biophysical and structural characterization
Q40901260	An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions
Q53165879	An investigation into the origin of the biased agonism associated with the urotensin II receptor activation.
Q40990314	Analysis of Human Dopamine D3 Receptor Quaternary Structure
Q64110733	Analysis of tractable allosteric sites in G protein-coupled receptors
Q33803979	Anti-HIV drug development through computational methods
Q31170483	Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure
Q39095586	Anti-HIV-1 peptide derivatives based on the HIV-1 Co-receptor CXCR4.
Q51741248	Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives.
Q37701720	Antibody epitopes on g protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers.
Q30580101	Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers
Q53468087	Apelinergic System Structure and Function.
Q30363845	Applications for mass spectrometry in the study of ion channel structure and function.
Q36848077	Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis
Q34295521	Assessing the relative stability of dimer interfaces in g protein-coupled receptors
Q28534461	Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors
Q46253588	Assessment of the transmembrane domain structures in GPCR Dock 2013 models
Q40413162	Attenuation of chemokine receptor function and surface expression as an immunomodulatory strategy employed by human cytomegalovirus is linked to vGPCR US28.
Q99635214	Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid N-Hydroxysuccinimide Ester (6-[18F]SFPy)
Q35181324	Automated sample-scanning methods for radiation damage mitigation and diffraction-based centering of macromolecular crystals.
Q26749791	Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization
Q39184086	Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitors
Q51250449	Beta2-adrenergic receptor homodimers: Role of transmembrane domain 1 and helix 8 in dimerization and cell surface expression.
Q41455641	Biased Gs versus Gq proteins and β-arrestin signaling in the NK1 receptor determined by interactions in the water hydrogen bond network
Q38209355	Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
Q40323977	Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7.
Q26823970	Biased and g protein-independent signaling of chemokine receptors
Q57460407	Biased antagonism of CXCR4 avoids antagonist tolerance
Q39426584	Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective
Q47316404	Bicyclic peptides with optimized ring size inhibit human plasma kallikrein and its orthologues while sparing paralogous proteases
Q30410723	Bihelix: Towards de novo structure prediction of an ensemble of G-protein coupled receptor conformations
Q27693321	Bioinformatic analysis of HIV-1 entry and pathogenesis
Q35971498	Biological Significance of GPCR Heteromerization in the Neuro-Endocrine System
Q47664682	Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer
Q37599363	Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases
Q27676919	Biophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design
Q44679352	Biophysical and structural investigation of bacterially expressed and engineered CCR5, a G protein-coupled receptor
Q33929146	Biophysical mapping of the adenosine A2A receptor
Q46631904	Biosynthesis and spectroscopic characterization of 2-TM fragments encompassing the sequence of a human GPCR, the Y4 receptor
Q35216669	Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies
Q33924007	Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)
Q50970453	C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.
Q35956560	CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant
Q38005459	CCR5 inhibitors: emergence, success, and challenges
Q64033776	CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
Q33907480	CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist
Q35173452	CXC chemokine CXCL12 and its receptor CXCR4 in tree shrews (Tupaia belangeri): structure, expression and function
Q41944437	CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1α and ubiquitin
Q33677057	CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
Q35223948	CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.
Q35995068	CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia-reperfusion injury
Q40962002	CXCR4 expression is associated with time-course permanent and temporary myocardial infarction in rats
Q104064730	CXCR4 in Waldenström's Macroglobulinema: chances and challenges
Q33909518	CXCR4 pathway associated with family history of melanoma
Q55513575	CXCR7 Targeting and Its Major Disease Relevance.
Q54976504	CXCR7/ACKR3-targeting ligands interfere with X7 HIV-1 and HIV-2 entry and replication in human host cells.
Q35842577	Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells
Q27311427	Cardiac contractility structure-activity relationship and ligand-receptor interactions; the discovery of unique and novel molecular switches in myosuppressin signaling
Q84580235	Cell signalling caught in the act
Q39055149	Cell-free expression, purification, and ligand-binding analysis of Drosophila melanogaster olfactory receptors DmOR67a, DmOR85b and DmORCO.
Q35156750	Changes in conformation at the cytoplasmic ends of the fifth and sixth transmembrane helices of a yeast G protein-coupled receptor in response to ligand binding
Q35214469	Characterization of G protein coupling mediated by the conserved D134(3.49) of DRY motif, M241(6.34), and F251(6.44) residues on human CXCR1.
Q53437158	Characterization of adenosine receptor in its native environment: insights from molecular dynamics simulations of palmitoylated/glycosylated, membrane-integrated human A(2B) adenosine receptor.
Q35626957	Characterization of lipid matrices for membrane protein crystallization by high-throughput small angle X-ray scattering
Q38077229	Characterization of the dynamic events of GPCRs by automated computational simulations
Q30411043	Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins
Q35276881	Characterizing protein interactions employing a genome-wide siRNA cellular phenotyping screen
Q36796931	Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.
Q35528569	Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
Q37827607	Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function
Q37608845	Chemokine oligomerization in cell signaling and migration
Q27007078	Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?
Q38172960	Chemokine receptor modeling: an interdisciplinary approach to drug design
Q33810517	Chemokine receptor oligomerization and allostery
Q38908803	Chemokines and their receptors: insights from molecular modeling and crystallography
Q47154563	Chemokines from a Structural Perspective
Q35753971	Cloning, expression and identification of an isoform of human stromal cell derived factor-1α
Q52660783	Closely related, yet unique: Distinct homo- and heterodimerization patterns of G protein coupled chemokine receptors and their fine-tuning by cholesterol.
Q57800914	Closing the Ring: A Fourth Extracellular Loop in Chemokine Receptors
Q37236116	Cofactoring and dimerization of proteinase-activated receptors
Q34026765	Collation and data-mining of literature bioactivity data for drug discovery
Q92669282	Combinatorial allosteric modulation of agonist response in a self-interacting G-protein coupled receptor
Q42128989	Comparative fluorescence resonance energy transfer analysis of metabotropic glutamate receptors: implications about the dimeric arrangement and rearrangement upon ligand bindings
Q33565687	Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors
Q30561114	Comparison of fragments comprising the first two helices of the human Y4 and the yeast Ste2p G-protein-coupled receptors
Q36479708	Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds
Q35168275	Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor
Q30423071	Compound activity prediction using models of binding pockets or ligand properties in 3D.
Q34669357	Comprehensive analysis of host gene expression in Autographa californica nucleopolyhedrovirus-infected Spodoptera frugiperda cells
Q41888022	Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists
Q27001137	Computational approaches for modeling GPCR dimerization
Q26746941	Computational approaches in target identification and drug discovery
Q33942265	Computational design of membrane proteins
Q39174440	Computational insights into the binding mechanism of antagonists with neuropeptide B/W receptor 1.
Q46477869	Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach
Q28537984	Computational prediction of alanine scanning and ligand binding energetics in G-protein coupled receptors
Q91370562	Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation
Q30427185	Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding
Q28543955	Conformational antibody binding to a native, cell-free expressed GPCR in block copolymer membranes
Q50958236	Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors.
Q98772154	Conformational dynamics of a G protein-coupled receptor helix 8 in lipid membranes
Q35541732	Conformational dynamics of single G protein-coupled receptors in solution
Q48012664	Conformational restriction of G-proteins Coupled Receptors (GPCRs) upon complexation to G-proteins: a putative activation mode of GPCRs?
Q27675253	Conopeptide -TIA Defines a New Allosteric Site on the Extracellular Surface of the 1B-Adrenoceptor
Q34481420	Conserved Residues Control Activation of Mammalian G Protein-Coupled Odorant Receptors
Q42212503	Considerations of Protein Subpockets in Fragment-Based Drug Design
Q34565057	Constitutively active CCR5 chemokine receptors differ in mediating HIV envelope-dependent fusion
Q90592857	Constraints on GPCR Heterodimerization Revealed by the Type-4 Induced-Association BRET Assay
Q39005448	Contribution of heteromerization to G protein-coupled receptor function
Q91910509	Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment
Q59335725	Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model
Q34292126	Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations
Q42183626	Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor
Q37479274	Critical role in CXCR4 signaling and internalization of the polypeptide main chain in the amino terminus of SDF-1α probed by novel N-methylated synthetically and modularly modified chemokine analogues
Q38208097	Cross-saturation and transferred cross-saturation experiments
Q56648567	CrossTalk proposal: Weighing the evidence for Class A GPCR dimers, the evidence favours dimers
Q37563536	Crucial positively charged residues for ligand activation of the GPR35 receptor
Q24305457	Crystal structure of a lipid G protein-coupled receptor
Q27676608	Crystal structure of oligomeric β1-adrenergic G protein–coupled receptors in ligand-free basal state
Q52645818	Crystal structure of the human 5-HT1B serotonin receptor bound to an inverse agonist.
Q27696899	Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant
Q27678133	Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Q30406181	Crystallization chaperone strategies for membrane proteins
Q42006253	Crystallization of G protein-coupled receptors
Q35090508	Crystallizing Membrane Proteins in Lipidic Mesophases. A Host Lipid Screen
Q37084925	Crystallizing membrane proteins for structure-function studies using lipidic mesophases
Q37943570	Crystallizing membrane proteins using lipidic bicelles
Q34398719	Current progress in antiviral strategies
Q39970371	Current trends in α-helical membrane protein crystallization: an update.
Q38124801	Cyclotides as grafting frameworks for protein engineering and drug design applications.
Q35737318	Databases in SenseLab for the genomics, proteomics, and function of olfactory receptors
Q100307205	Deciphering collaborative sidechain motions in proteins during molecular dynamics simulations
Q39775436	Design and Synthesis of Peptide YY Analogues with C-terminal Backbone Amide-to-Ester Modifications
Q92992890	Design and development of stapled transmembrane peptides that disrupt the activity of G-protein-coupled receptor oligomers
Q59359060	Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery
Q35220086	Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.
Q38791942	Design of HIV Coreceptor Derived Peptides That Inhibit Viral Entry at Submicromolar Concentrations.
Q36465556	Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity
Q37025671	Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents
Q33874555	Design, synthesis, and biological characterization of novel PEG-linked dimeric modulators for CXCR4
Q48254950	Design, synthesis, and biological evaluation of CXCR4 ligands
Q102388720	Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting
Q39204577	Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues
Q36152480	Detecting the native ligand orientation by interfacial rigidity: SiteInterlock
Q47246062	Detection of intermolecular transferred-NOE interactions in small and medium size protein complexes: RANTES complexed with a CCR5 N-terminal peptide
Q39157622	Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis
Q58357649	Developing DNP/Solid-State NMR Spectroscopy of Oriented Membranes
Q39619500	Development and application of fluorescent SDF-1 derivatives
Q34647300	Development of 7TM receptor-ligand complex models using ligand-biased, semi-empirical helix-bundle repacking in torsion space: application to the agonist interaction of the human dopamine D2 receptor
Q36212626	Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library
Q27305638	Development of a unique small molecule modulator of CXCR4
Q42746161	Development of an Automated High Throughput LCP-FRAP Assay to Guide Membrane Protein Crystallization in Lipid Mesophases
Q37979306	Development of novel CXCR4-based therapeutics
Q47260364	Different contribution of chemokine N-terminal features attest a different ligand binding mode and a bias towards activation of the atypical chemokine receptor ACKR3/CXCR7 compared to CXCR4 and CXCR3.
Q30397614	Differential Contribution of Transmembrane Domains IV, V, VI, and VII to Human Angiotensin II Type 1 Receptor Homomer Formation
Q36088280	Differential Virtual Screening (DVS) with Active and Inactive Molecular Models for Finding and Profiling GPCR Modulators: Case of the CCK1 Receptor
Q35900688	Differential determinants for coupling of distinct G proteins with the class B secretin receptor
Q41818732	Differential interactions of fluorescent agonists and antagonists with the yeast G protein coupled receptor Ste2p
Q35625928	Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol
Q35126350	Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors
Q27670749	Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC
Q89530060	Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors
Q37125106	Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists
Q35036663	Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists
Q34582707	Discovery of GPCR ligands for probing signal transduction pathways
Q99200481	Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach
Q42144564	Discovery of novel N-aryl piperazine CXCR4 antagonists
Q83100630	Discovery of novel stem cell mobilizers that target the CXCR4 receptor
Q40686762	Discovery of tetrahydroisoquinoline-based CXCR4 antagonists
Q37680038	Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse
Q36283412	Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface
Q35421675	Dissecting the functions of conserved prolines within transmembrane helices of the D2 dopamine receptor.
Q35906663	Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses.
Q61448446	Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation
Q26782778	Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
Q26852976	Diversity and modularity of G protein-coupled receptor structures
Q34049826	Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
Q45920467	Do plants contain g protein-coupled receptors?
Q35740222	Domain coupling in GPCRs: the engine for induced conformational changes
Q34386483	Downsizing a human inflammatory protein to a small molecule with equal potency and functionality.
Q36334083	Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).
Q35718010	Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines
Q48298916	Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA.
Q36182026	Dynamic Cholesterol-Conditioned Dimerization of the G Protein Coupled Chemokine Receptor Type 4.
Q55195798	Dynamic tuneable G protein-coupled receptor monomer-dimer populations.
Q38552558	Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Q37099769	Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice
Q36220520	Effects of lipid-analog detergent solubilization on the functionality and lipidic cubic phase mobility of the Torpedo californica nicotinic acetylcholine receptor
Q28572239	Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling
Q42707545	Efficient Synthesis of Unsaturated 1-Monoacyl Glycerols for in meso Crystallization of Membrane Proteins
Q54765737	Elastic network normal mode dynamics reveal the GPCR activation mechanism.
Q38004660	Electron crystallography--the waking beauty of structural biology
Q36275325	Electrostatic Similarity Analysis of Human β-Defensin Binding in the Melanocortin System
Q27309182	Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.
Q30577284	Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4.
Q36629045	Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3.
Q64245553	Emerging Diversity in Lipid-Protein Interactions
Q33763369	Emerging concepts and approaches for chemokine-receptor drug discovery
Q38125563	Emerging paradigms in GPCR allostery: implications for drug discovery
Q27009220	Endogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulations
Q35266466	Engineering a prokaryotic Cys-loop receptor with a third functional domain
Q41873089	Engineering an ultra-thermostable β(1)-adrenoceptor
Q26769017	Engineering therapeutic antibodies targeting G-protein-coupled receptors
Q37033314	Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma
Q37865808	Escaping the flatlands: new approaches for studying the dynamic assembly and activation of GPCR signaling complexes.
Q35682331	Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor
Q39554621	Evaluation of the Pichia pastoris expression system for the production of GPCRs for structural analysis
Q89137102	Evolution of chemokine receptors is driven by mutations in the sodium binding site
Q36003168	Evolution of coreceptor utilization to escape CCR5 antagonist therapy.
Q42251205	Evolutionary Analysis of Functional Divergence among Chemokine Receptors, Decoy Receptors, and Viral Receptors
Q54563068	Exocyclic control of turn induction in macrocyclic peptide scaffolds.
Q38976083	Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models.
Q36001149	Experiment-Guided Molecular Modeling of Protein-Protein Complexes Involving GPCRs
Q38819497	Exploiting agonist biased signaling of chemokines to target cancer.
Q40487821	Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization
Q51550199	Exploring 3D structure of human gonadotropin hormone receptor at antagonist state using homology modeling, molecular dynamic simulation, and cross-docking studies.
Q34540970	Exploring binding properties of agonists interacting with a δ-opioid receptor
Q41667510	Exploring the binding mechanisms of MIF to CXCR2 using theoretical approaches
Q61803003	Expression and Purification of Chemokine MIP-3α (CCL20) through a Calmodulin-Fusion Protein System
Q33939900	Expression and biophysical analysis of a triple-transmembrane domain-containing fragment from a yeast G protein-coupled receptor
Q49671624	Expression of CXC-motif-chemokine 12 and the receptor C-X-C receptor 4 in glioma and theeffect on peritumoral brain edema.
Q38693302	Extracellular Ubiquitin: Role in Myocyte Apoptosis and Myocardial Remodeling
Q35140322	Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors
Q33809888	First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
Q27004213	Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors
Q38087291	Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
Q41916230	Fractal dimension as a measure of surface roughness of G protein-coupled receptors: implications for structure and function
Q34569177	Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction.
Q36775158	Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors
Q28276613	Function-specific virtual screening for GPCR ligands using a combined scoring method
Q46494176	Functional Consequences of GPCR Heterodimerization: GPCRs as Allosteric Modulators
Q53242934	Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists.
Q37625867	Functional assay for T4 lysozyme-engineered G protein-coupled receptors with an ion channel reporter.
Q34450164	Functional fusions of T4 lysozyme in the third intracellular loop of a G protein-coupled receptor identified by a random screening approach in yeast
Q92547985	Functional mimetic of the G-protein coupled receptor CXCR4 on a soluble antibody scaffold
Q38118062	Functional significance of serotonin receptor dimerization
Q36033453	Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors
Q39395077	G Protein-Coupled Estrogen Receptor (GPER) Agonist Dual Binding Mode Analyses toward Understanding of its Activation Mechanism: A Comparative Homology Modeling Approach
Q51090373	G Protein-Coupled Receptor Kinase 3 and Protein Kinase C Phosphorylate the Distal C-Terminal Tail of the Chemokine Receptor CXCR4 and Mediate Recruitment of β-Arrestin.
Q26752403	G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs
Q41907669	G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient
Q35987700	G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions
Q37680849	G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives
Q46040981	G protein-coupled receptors in the spot light
Q35065927	G protein-coupled receptors--recent advances
Q82676932	G protein-coupled receptors: Insights into chemokine receptors
Q55278334	G protein-coupled receptors: the evolution of structural insight.
Q27676934	G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody
Q30427675	G-protein-coupled receptor structure, ligand binding and activation as studied by solid-state NMR spectroscopy
Q38266283	G-protein-coupled receptor type A heteromers as an emerging therapeutic target.
Q50643791	GGIP: Structure and sequence-based GPCR-GPCR interaction pair predictor.
Q47274809	GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative Agents.
Q36922998	GPCR activation: protonation and membrane potential
Q38810192	GPCR agonist binding revealed by modeling and crystallography
Q58584501	GPCR homology model template selection benchmarking: Global versus local similarity measures
Q21198901	GPCR oligomers in pharmacology and signaling
Q40616754	GPCR stabilization using the bicelle-like architecture of mixed sterol-detergent micelles
Q34485830	GPCR-I-TASSER: A Hybrid Approach to G Protein-Coupled Receptor Structure Modeling and the Application to the Human Genome
Q33909144	GPCR-SSFE: a comprehensive database of G-protein-coupled receptor template predictions and homology models
Q38139871	GPCR: G protein complexes--the fundamental signaling assembly
Q55096303	GPCRdb: an information system for G protein-coupled receptors.
Q38274861	Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5).
Q90312422	Generating Recombinant Antibodies to Membrane Proteins through Phage Display
Q28087587	Generic GPCR residue numbers - aligning topology maps while minding the gaps
Q28572982	Genetically encoded chemical probes in cells reveal the binding path of urocortin-I to CRF class B GPCR
Q37411986	Genetically-encoded molecular probes to study G protein-coupled receptors
Q33809669	Global fold of human cannabinoid type 2 receptor probed by solid-state 13C-, 15N-MAS NMR and molecular dynamics simulations
Q38057852	Grand opening of structure-guided design for novel opioids.
Q36588528	HIV coreceptor tropism determination and mutational pattern identification
Q35853012	HIV-1 antiretroviral drug therapy
Q27008983	HIV: cell binding and entry
Q24306365	HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Q39414464	Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
Q40109819	Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology.
Q36359772	Harvesting and cryo-cooling crystals of membrane proteins grown in lipidic mesophases for structure determination by macromolecular crystallography
Q92132459	Helix 8 is the essential structural motif of mechanosensitive GPCRs
Q34715575	Helix 8 of the M1 muscarinic acetylcholine receptor: scanning mutagenesis delineates a G protein recognition site.
Q39455064	Helix 8 plays a crucial role in bradykinin B(2) receptor trafficking and signaling
Q37408417	Herb-target interaction network analysis helps to disclose molecular mechanism of traditional Chinese medicine
Q38180332	Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?
Q37379456	Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance
Q35279688	Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.
Q37819146	Heterophilic chemokine receptor interactions in chemokine signaling and biology
Q27671514	High Resolution Structure of the ba3 Cytochrome c Oxidase from Thermus thermophilus in a Lipidic Environment
Q54175856	High end GPCR design: crafted ligand design and druggability analysis using protein structure, lipophilic hotspots and explicit water networks.
Q37909724	High throughput platforms for structural genomics of integral membrane proteins
Q27675402	High-resolution crystal structure of human protease-activated receptor 1
Q24301044	High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875
Q35918124	Highly Accurate Structure-Based Prediction of HIV-1 Coreceptor Usage Suggests Intermolecular Interactions Driving Tropism
Q42212856	Hologram quantitative structure activity relationship, docking, and molecular dynamics studies of inhibitors for CXCR4.
Q37922092	Homeostatic chemokine receptors and organ-specific metastasis
Q26752632	Homing in hematopoietic stem cells: focus on regulatory role of CXCR7 on SDF1a/CXCR4 axis
Q35181896	Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor
Q36087159	Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation
Q42806068	Homology modeling of a Class A GPCR in the inactive conformation: A quantitative analysis of the correlation between model/template sequence identity and model accuracy
Q35967081	Homology modeling of class a G protein-coupled receptors
Q38856178	Homology-based Modeling of Rhodopsin-like Family Members in the Inactive State: Structural Analysis and Deduction of Tips for Modeling and Optimization
Q39469192	How to Choose the Suitable Template for Homology Modelling of GPCRs: 5-HT7 Receptor as a Test Case.
Q51702848	How transmembrane peptides insert and orientate in biomembranes: a combined experimental and simulation study.
Q41403314	Human adenosine A2A receptor binds calmodulin with high affinity in a calcium-dependent manner.
Q37318727	Human β-defensin-3 structure motifs that are important in CXCR4 antagonism
Q39442795	Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression.
Q37979710	Ice breaking in GPCR structural biology
Q37189430	Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils
Q39074380	Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor
Q38915518	Identification of Similar Binding Sites to Detect Distant Polypharmacology
Q48215156	Identification of Two Distinct Sites for Antagonist and Biased Agonist Binding to the Human Chemokine Receptor CXCR3.
Q51734324	Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.
Q38859512	Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses
Q28480517	Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells
Q35554301	Identification of destabilizing and stabilizing mutations of Ste2p, a G protein-coupled receptor in Saccharomyces cerevisiae
Q38799672	Identification of novel 2-(1H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth and motility
Q46095475	Identification of residues involved in homodimer formation located within a β-strand region of the N-terminus of a Yeast G protein-coupled receptor
Q33887246	Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands
Q35052556	Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.
Q36059926	Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies.
Q56987439	Identification of the first surrogate agonists for the G protein-coupled receptor GPR132
Q24594672	Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function
Q38022430	Imaging agents for the chemokine receptor 4 (CXCR4).
Q35800908	Imaging of protein crystals with two-photon microscopy
Q36222134	Impact of Lipid Composition and Receptor Conformation on the Spatio-temporal Organization of μ-Opioid Receptors in a Multi-component Plasma Membrane Model
Q38023797	Impact of helix irregularities on sequence alignment and homology modeling of G protein-coupled receptors
Q48360426	Importance of the second extracellular loop for melatonin MT1 receptor function and absence of melatonin binding in GPR50.
Q36760742	Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection
Q56992010	In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions
Q35057759	In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.
Q41533540	In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study
Q42730804	In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases
Q52665081	In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.
Q36858819	In vitro expression and analysis of the 826 human G protein-coupled receptors
Q53076975	In-silico guided discovery of novel CCR9 antagonists.
Q38588687	Incorporation of Non-Canonical Amino Acids
Q47213731	Increasing the Stability of Recombinant Human Green Cone Pigment.
Q36317014	Individual protomers of a G protein-coupled receptor dimer integrate distinct functional modules.
Q37714248	Inhibiting metastatic breast cancer cell migration via the synergy of targeted, pH-triggered siRNA delivery and chemokine axis blockade
Q36627752	Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model
Q36327374	Initial assessment of the role of CXC chemokine receptor 4 after polytrauma
Q36218464	Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83.
Q90501515	Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach
Q37995725	Insights into the activation mechanism of the visual receptor rhodopsin
Q41728362	Insights into the binding modes of CC chemokine receptor 4 (CCR4) inhibitors: a combined approach involving homology modelling, docking, and molecular dynamics simulation studies
Q39165104	Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures.
Q52616203	Insights into the mechanism of enhanced mobilization of hematopoietic progenitor cells and release of CXCL12 by a combination of AMD3100 and aminoglycoside-polyarginine conjugates.
Q35168976	Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors.
Q28284361	Insights into the molecular evolution of oxytocin receptor ligand binding
Q38247995	Insights into the structural biology of G-protein coupled receptors impacts drug design for central nervous system neurodegenerative processes
Q34393487	Insights into the structure of class B GPCRs
Q34490720	Insights into the structure, correlated motions, and electrostatic properties of two HIV-1 gp120 V3 loops
Q46506229	Instant Integrated Ultradeep Quantitative-structural Membrane Proteomics Discovered Post-translational Modification Signatures for Human Cys-loop Receptor Subunit Bias.
Q28477824	Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment
Q31118641	Integrating structural and mutagenesis data to elucidate GPCR ligand binding.
Q47270616	Interaction of Monomeric Interleukin-8 with CXCR1 Mapped by Proton-Detected Fast MAS Solid-State NMR.
Q40058610	Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.
Q91866609	Interfaces Between Alpha-helical Integral Membrane Proteins: Characterization, Prediction, and Docking
Q35383835	International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
Q37432097	International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors
Q35977592	Intracellular Loop 2 Peptides of the Human 5HT1a Receptor are Differential Activators of Gi.
Q52589354	Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
Q40420305	Intracellular allosteric antagonism of the CCR9 receptor
Q41037672	Investigation of Inhibition Mechanism of Chemokine Receptor CCR5 by Micro-second Molecular Dynamics Simulations.
Q30360845	Invited review: GPCR structural characterization: Using fragments as building blocks to determine a complete structure.
Q90044352	Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding
Q42009373	Large multiple transmembrane domain fragments of a G protein-coupled receptor: biosynthesis, purification, and biophysical studies
Q26866010	Large-scale production and protein engineering of G protein-coupled receptors for structural studies
Q33791008	Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicine
Q31088115	Leu128(3.43) (l128) and Val247(6.40) (V247) of CXCR1 are critical amino acid residues for g protein coupling and receptor activation
Q37921853	Lifting the lid on GPCRs: the role of extracellular loops
Q36153222	Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor
Q37602190	Ligand binding pocket of a novel Allatostatin receptor type C of stick insect, Carausius morosus.
Q38014954	Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors
Q38462134	Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX.
Q38031893	Ligand-receptor interaction platforms and their applications for drug discovery.
Q38338198	Light on the structure of thromboxane A₂receptor heterodimers.
Q47850453	Limiting Assumptions in the Design of Peptidomimetics
Q34490693	Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonists
Q35008243	Lipid cubic phase as a membrane mimetic for integral membrane protein enzymes
Q35187977	Lipidic cubic phase technologies for membrane protein structural studies
Q49084735	Loop prediction for a GPCR homology model: algorithms and results.
Q41482422	Loss of constitutive activity is correlated with increased thermostability of the human adenosine A2A receptor
Q34543093	MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development
Q37117350	Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.
Q41694901	Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer.
Q52573419	Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning
Q36430829	Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping
Q64898242	Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer.
Q42737253	Mapping the ligand-binding site on a G protein-coupled receptor (GPCR) using genetically encoded photocrosslinkers
Q37563941	Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display
Q39126530	Mechanisms of Regulation of the Chemokine-Receptor Network.
Q30155276	Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes
Q28072820	Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function
Q27329683	Membrane-sensitive conformational states of helix 8 in the metabotropic Glu2 receptor, a class C GPCR
Q40274047	Metal ions-binding T4 lysozyme as an intramolecular protein purification tag compatible with X-ray crystallography
Q26991511	Metaphors, naming and new signaling paradigms by G-protein-coupled receptors
Q38318691	Methodological advances: the unsung heroes of the GPCR structural revolution.
Q45943415	Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
Q30412884	Methods of protein structure comparison
Q34548734	Methods used to study the oligomeric structure of G-protein-coupled receptors
Q38876505	Micelle-Enhanced Bioorthogonal Labeling of Genetically Encoded Azido Groups on the Lipid-Embedded Surface of a GPCR.
Q41656733	Micro-scale and rapid expression screening of highly expressed and/or stable membrane protein variants in Saccharomyces cerevisiae
Q40370946	Microscopic binding of M5 muscarinic acetylcholine receptor with antagonists by homology modeling, molecular docking, and molecular dynamics simulation
Q100385850	Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands
Q41709018	Mifepristone inhibits ovarian cancer metastasis by intervening in SDF-1/CXCR4 chemokine axis
Q34766579	Milligram production and biological activity characterization of the human chemokine receptor CCR3.
Q45776913	Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation
Q39537387	Modeling Complexes of Transmembrane Proteins: Systematic Analysis of ProteinProtein Docking Tools
Q28478103	Modeling of human prokineticin receptors: interactions with novel small-molecule binders and potential off-target drugs
Q39310535	Modeling of mammalian olfactory receptors and docking of odorants
Q35625908	Modeling of the OX1R-orexin-A complex suggests two alternative binding modes.
Q34222925	Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs.
Q42256464	Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism.
Q36474046	Modelling dynamics in protein crystal structures by ensemble refinement
Q41940041	Modulation of constitutive activity and signaling bias of the ghrelin receptor by conformational constraint in the second extracellular loop
Q99615057	Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors
Q35834471	Molecular Insights into the Transmembrane Domain of the Thyrotropin Receptor
Q38796479	Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5).
Q36541370	Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical Probes
Q36002904	Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor
Q36619992	Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations
Q42393773	Molecular basis for the antagonistic activity of an anti-CXCR4 antibody
Q34018861	Molecular basis of ligand dissociation in β-adrenergic receptors
Q35085038	Molecular basis of secretin docking to its intact receptor using multiple photolabile probes distributed throughout the pharmacophore
Q28115398	Molecular characterization of oxysterol binding to the Epstein-Barr virus-induced gene 2 (GPR183)
Q27681274	Molecular control of δ-opioid receptor signalling
Q55003590	Molecular details of dimerization kinetics reveal negligible populations of transient µ-opioid receptor homodimers at physiological concentrations.
Q47820364	Molecular dynamics simulation of chemokine receptors in lipid bilayer: a case study on C-C chemokine receptor type 2.
Q39752554	Molecular dynamics simulations and docking studies on 3D models of the heterodimeric and homodimeric 5-HT(2A) receptor subtype
Q51678306	Molecular dynamics simulations and structure-based network analysis reveal structural and functional aspects of G-protein coupled receptor dimer interactions.
Q42754544	Molecular dynamics simulations on the Tre1 G protein-coupled receptor: exploring the role of the arginine of the NRY motif in Tre1 structure
Q28729987	Molecular evolution of a peptide GPCR ligand driven by artificial neural networks
Q33819076	Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases
Q42582195	Molecular modeling of the M3 acetylcholine muscarinic receptor and its binding site
Q27325455	Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.
Q38107508	Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists
Q46409320	Molecular modeling studies give hint for the existence of a symmetric hβ₂R-Gαβγ-homodimer
Q21559473	Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop
Q24616040	Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop
Q34327700	Molecular signatures of G-protein-coupled receptors
Q35471523	Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways
Q28740892	Monoolein lipid phases as incorporation and enrichment materials for membrane protein crystallization
Q39525809	Multi-Component Protein - Protein Docking Based Protocol with External Scoring for Modeling Dimers of G Protein-Coupled Receptors
Q37676906	Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation
Q61218037	Multi-objective active machine learning rapidly improves structure-activity models and reveals new protein-protein interaction inhibitors
Q28477879	Multidimensional scaling reveals the main evolutionary pathways of class A G-protein-coupled receptors
Q27902288	Multiple conformational states in retrospective virtual screening – homology models vs. crystal structures: beta-2 adrenergic receptor case study
Q63547192	Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance
Q49343068	Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.
Q49349334	Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Q27674422	N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor
Q36403522	NMR in the Analysis of Functional Chemokine Interactions and Drug Discovery
Q24324423	NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains
Q42219237	NMR observation of HIV-1 gp120 conformational flexibility resulting from V3 truncation
Q30155502	NMR structures of polytopic integral membrane proteins
Q47194753	Na+-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1.
Q27690729	Nanobody stabilization of G protein-coupled receptor conformational states.
Q30419814	Naturally evolved G protein-coupled receptors adopt metastable conformations
Q37050877	New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.
Q37940726	New amphiphiles for membrane protein structural biology
Q26991761	New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors
Q40177843	New insights into the stereochemical requirements of the bradykinin B2 receptor antagonists binding
Q38815332	New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.
Q35765639	Novel Scaffold Identification of mGlu1 Receptor Negative Allosteric Modulators Using a Hierarchical Virtual Screening Approach.
Q37203610	Novel insights on thyroid-stimulating hormone receptor signal transduction
Q34457615	Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling
Q37348978	Novel structural and functional insights into M3 muscarinic receptor dimer/oligomer formation
Q26865384	OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Q90679977	Oligomeric Receptor Complexes and Their Allosteric Receptor-Receptor Interactions in the Plasma Membrane Represent a New Biological Principle for Integration of Signals in the CNS
Q26752261	Oligomerization of GPCRs involved in endocrine regulation
Q43084203	On homology modeling of the M₂ muscarinic acetylcholine receptor subtype.
Q24610487	One-step immunopurification and lectinochemical characterization of the Duffy atypical chemokine receptor from human erythrocytes
Q36096058	Opioid receptors: Structural and mechanistic insights into pharmacology and signaling
Q27002925	Opioid receptors: toward separation of analgesic from undesirable effects
Q36343219	Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening
Q37184416	Optimization of purification and refolding of the human chemokine receptor CXCR1 improves the stability of proteoliposomes for structure determination
Q30579021	Optogenetic control of chemokine receptor signal and T-cell migration.
Q41867290	Organization and dynamics of the N-terminal domain of chemokine receptor CXCR1 in reverse micelles: effect of graded hydration
Q58490040	Orthosteric and allosteric action of the C5a receptor antagonists
Q34918713	Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor
Q50714361	Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.
Q30401692	Overcoming barriers to membrane protein structure determination
Q35214601	Overexpression of membrane proteins from higher eukaryotes in yeasts
Q38709034	Oxabicycloheptene Sulfonate Protects Against β-Amyloid-induced Toxicity by Activation of PI3K/Akt and ERK Signaling Pathways Via GPER1 in C6 Cells.
Q38210350	Oxysterol-EBI2 signaling in immune regulation and viral infection
Q34201750	Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling.
Q37608494	Pancreatic polypeptide is recognized by two hydrophobic domains of the human Y4 receptor binding pocket.
Q48624133	Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.
Q37421226	Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein
Q38003847	Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).
Q30352117	Peptide and protein-based inhibitors of HIV-1 co-receptors
Q55503101	Peptide density targets and impedes triple negative breast cancer metastasis.
Q35179408	Peptide ligand recognition by G protein-coupled receptors
Q39510436	Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression.
Q35922555	Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
Q59210137	Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studies
Q90303496	Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity
Q38614708	Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.
Q34007358	Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3
Q37893687	Pharmacological modulation of chemokine receptor function.
Q47559285	Pharmacophore modeling, atom based 3D-QSAR and Molecular docking approaches to screen C-X-C chemokine receptor type 4 antagonists as microbicides for human immunodeficiency virus-1.
Q26822470	Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Q92541764	Ping-Pong-Tumor and Host in Pancreatic Cancer Progression
Q41243070	Platform for the rapid construction and evaluation of GPCRs for crystallography in Saccharomyces cerevisiae
Q26849743	Post-expression strategies for structural investigations of membrane proteins
Q39513365	Potent CXCR4 antagonists containing amidine type Peptide bond isosteres
Q36195192	Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus
Q43520105	Predicted 3D structures of olfactory receptors with details of odorant binding to OR1G1.
Q46248274	Predicted ligands for the human urotensin-II G protein-coupled receptor with some experimental validation
Q36471233	Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor
Q56985645	Prediction of a Ligand-Binding Niche within a Human Olfactory Receptor by Combining Site-Directed Mutagenesis with Dynamic Homology Modeling
Q39281418	Prediction of the Human EP1 Receptor Binding Site by Homology Modeling and Molecular Dynamics Simulation
Q39017581	Preferential recognition of monomeric CCR5 expressed in cultured cells by the HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1.
Q27319797	Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-association
Q36756930	Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.
Q36077712	Preparation of an activated rhodopsin/transducin complex using a constitutively active mutant of rhodopsin
Q36630298	Probing GPCR structure: adenosine and P2Y nucleotide receptors
Q91583484	Probing the Druggablility on the Interface of the Protein-Protein Interaction and Its Allosteric Regulation Mechanism on the Drug Screening for the CXCR4 Homodimer
Q38671723	Production of Chemokine/Chemokine Receptor Complexes for Structural Biophysical Studies.
Q28476523	Production of a bioengineered G-protein coupled receptor of human formyl peptide receptor 3
Q50512769	Production of the stable human histamine H₁ receptor in Pichia pastoris for structural determination.
Q38037185	Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit
Q37880053	Progress in structure based drug design for G protein-coupled receptors
Q38136311	Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress
Q38083321	Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012.
Q38542935	Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists
Q39323119	Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer
Q44607630	Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5.
Q35844509	Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase
Q35051133	Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor
Q41980399	Qualifying a eukaryotic cell-free system for fluorescence based GPCR analyses
Q35611767	Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
Q36619594	Quantitatively resolving multivalent interactions on a macroscopic scale using force spectroscopy.
Q53188593	Radioligand binding analysis as a tool for quality control of GPCR production for structural characterization: adenosine A(2a)R as a template for study.
Q35557929	Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach
Q42323959	Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues
Q38973911	Rational design of CXCR4 specific antibodies with elongated CDRs
Q37400201	Real time monitoring of membrane GPCR reconstitution by plasmon waveguide resonance: on the role of lipids.
Q35048773	Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers
Q39263823	Rebuilding a macromolecular membrane complex at the atomic scale: case of the Kir6.2 potassium channel coupled to the muscarinic acetylcholine receptor M2.
Q41664350	Receptor Quaternary Organization Explains G Protein-Coupled Receptor Family Structure
Q34522748	Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.
Q34624051	Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs
Q36451989	Reengineering the collision coupling and diffusion mode of the A2A-adenosine receptor: palmitoylation in helix 8 relieves confinement
Q42183002	Referenced Single-Molecule Measurements Differentiate between GPCR Oligomerization States
Q28072580	Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26
Q38925254	Regulation, Signaling, and Physiological Functions of G-Proteins
Q36354912	Responsiveness of G protein-coupled odorant receptors is partially attributed to the activation mechanism
Q42269169	Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.
Q38476515	Review cyclic peptides on a merry-go-round; towards drug design
Q51393729	Revisiting the homology modeling of G-protein coupled receptors: β1-adrenoceptor as an example.
Q38862301	Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding
Q42334821	Role of SDF-1α/CXCR4 signaling pathway in clinicopathological features and prognosis of patients with nasopharyngeal carcinoma
Q38621958	Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.
Q42095761	Salt effects on the conformational stability of the visual G-protein-coupled receptor rhodopsin
Q38959024	Scavenging strategy for specific activity improvement: application to a new CXCR4-specific cyclopentapeptide positron emission tomography tracer
Q35763258	Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation
Q33926023	Selection of a CXCR4 antagonist from a human heavy chain CDR3-derived phage library
Q42021865	Selective mode of action of guanidine-containing non-peptides at human NPFF receptors
Q36186107	Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific
Q28649590	Sequence, structure and ligand binding evolution of rhodopsin-like G protein-coupled receptors: a crystal structure-based phylogenetic analysis
Q54707913	Short peptide constructs mimic agonist sites of AT(1)R and BK receptors.
Q92650126	Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective
Q34537921	Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
Q34012132	Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3
Q34574987	Small molecule inhibitors of CXCR4.
Q47651339	Spatial Intensity Distribution Analysis: Studies of G Protein-Coupled Receptor Oligomerisation
Q35486811	Stabilization of G protein-coupled receptors by point mutations
Q42863821	Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment
Q34752104	Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation
Q34550666	Structural Analysis of Chemokine Receptor-Ligand Interactions
Q51337340	Structural Analysis of the Histamine H1 Receptor.
Q92817538	Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7
Q27676926	Structural Basis for Molecular Recognition at Serotonin Receptors
Q27676584	Structural Characterization of an LPA1 Second Extracellular Loop Mimetic with a Self-Assembling Coiled-Coil Folding Constraint
Q38035296	Structural Diversity in Conserved Regions Like the DRY-Motif among Viral 7TM Receptors-A Consequence of Evolutionary Pressure?
Q26783016	Structural Studies of G Protein-Coupled Receptors
Q90659183	Structural Variability in the RLR-MAVS Pathway and Sensitive Detection of Viral RNAs
Q34631525	Structural analysis of a novel small molecule ligand bound to the CXCL12 chemokine
Q92619665	Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4
Q30152958	Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation with membrane proteins: implications for co-crystallization
Q37635253	Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.
Q41887436	Structural and functional roles of small group-conserved amino acids present on helix-H7 in the β(2)-adrenergic receptor
Q35790289	Structural aspects of M₃ muscarinic acetylcholine receptor dimer formation and activation
Q39197767	Structural assemblies of the di- and oligomeric G-protein coupled receptor TGR5 in live cells: an MFIS-FRET and integrative modelling study.
Q42380472	Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation
Q24305187	Structural basis for the binding of the membrane-proximal C-terminal region of chemokine receptor CCR2 with the cytosolic regulator FROUNT
Q96946563	Structural basis of CXC chemokine receptor 2 activation and signalling
Q33931230	Structural basis of G protein-coupled receptor-Gi protein interaction: formation of the cannabinoid CB2 receptor-Gi protein complex
Q90665799	Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses
Q64988502	Structural basis of coreceptor recognition by HIV-1 envelope spike.
Q90091039	Structural basis of ligand binding modes at the human formyl peptide receptor 2
Q37598462	Structural basis of ligand interaction with atypical chemokine receptor 3.
Q50965349	Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.
Q38204271	Structural biology of the S1P1 receptor
Q42270083	Structural biology. A new bundle of prospects for blocking HIV-1 entry
Q28910426	Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine
Q35652476	Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor
Q42156841	Structural biology. Viral chemokine mimicry
Q43235004	Structural biology: How opioid drugs bind to receptors
Q36181993	Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents
Q35554000	Structural characterization of triple transmembrane domain containing fragments of a yeast G protein-coupled receptor in an organic : aqueous environment by solution-state NMR spectroscopy
Q38895025	Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling
Q37511769	Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands
Q38114211	Structural determinants of arrestin functions
Q35626054	Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction
Q36044571	Structural dynamics and thermostabilization of neurotensin receptor 1
Q28481687	Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study
Q37854213	Structural insights into adrenergic receptor function and pharmacology
Q34218351	Structural insights into human GPCR protein OA1: a computational perspective.
Q39864197	Structural mechanisms of constitutive activation in the C5a receptors with mutations in the extracellular loops: molecular modeling study
Q24595276	Structural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor
Q38987183	Structural studies of G protein-coupled receptors
Q30401802	Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work
Q42131239	Structure and activation of the TSH receptor transmembrane domain
Q38292961	Structure and function of G protein-coupled receptor oligomers: implications for drug discovery
Q30382524	Structure and function of serotonin G protein-coupled receptors.
Q26824924	Structure determination of membrane proteins by nuclear magnetic resonance spectroscopy
Q42285749	Structure determination of membrane proteins in their native phospholipid bilayer environment by rotationally aligned solid-state NMR spectroscopy
Q28654490	Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy
Q37507076	Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists
Q24338769	Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator
Q24296388	Structure of an agonist-bound human A2A adenosine receptor
Q46221302	Structure of monomeric Interleukin-8 and its interactions with the N-terminal Binding Site-I of CXCR1 by solution NMR spectroscopy
Q27681431	Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli
Q27672832	Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
Q35592165	Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.
Q27679932	Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Q27674395	Structure of the agonist-bound neurotensin receptor
Q27674645	Structure of the chemokine receptor CXCR1 in phospholipid bilayers
Q47233334	Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.
Q39991433	Structure of the first sphingosine 1-phosphate receptor
Q24628686	Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Q41809765	Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode
Q100750121	Structure of the human gonadotropin-releasing hormone receptor GnRH1R reveals an unusual ligand binding mode
Q24595968	Structure of the human histamine H1 receptor complex with doxepin
Q27677951	Structure of the human smoothened receptor bound to an antitumour agent
Q24308048	Structure of the human κ-opioid receptor in complex with JDTic
Q27679151	Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Q45901542	Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor.
Q44267130	Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking
Q56991997	Structure-Based Discovery of Allosteric Modulators of Two Related Class B G-Protein-Coupled Receptors
Q28551072	Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications
Q38172457	Structure-based and fragment-based GPCR drug discovery
Q34676680	Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
Q46496124	Structure-based discovery of novel US28 small molecule ligands with different modes of action
Q38002626	Structure-based drug screening for G-protein-coupled receptors
Q35887252	Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4
Q36949884	Structure-based network analysis of an evolved G protein-coupled receptor homodimer interface.
Q30576993	Structure-function of the G protein-coupled receptor superfamily
Q34054895	Substructure-based virtual screening for adenosine A2A receptor ligands
Q93054793	Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination
Q39766459	Symmetrical bis-tertiary amines as novel CXCR4 inhibitors
Q35842651	Synergistic interactions between chemokine receptor elements in recognition of interleukin-8 by soluble receptor mimics.
Q83179227	Synthesis of heterologous G protein-coupled receptors in the methylotrophic yeast P. pastoris
Q51313427	Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
Q26770255	Synthetic Peptides as Protein Mimics
Q45361823	Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design
Q88994083	T4 lysozyme-facilitated crystallization of the human molybdenum cofactor-dependent enzyme mARC
Q42244148	T4-lysozyme fusion for the production of human formyl peptide receptors for structural determination
Q90179056	Tailored Lipoprotein-Like miRNA Delivery Nanostructure Suppresses Glioma Stemness and Drug Resistance through Receptor-Stimulated Macropinocytosis
Q35197000	Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular-regulated kinase-1/2 in restitution
Q35213463	Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis
Q35312229	The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions
Q38333255	The CXC chemokine receptors of fish: Insights into CXCR evolution in the vertebrates.
Q27670815	The Conformation and Orientation of a 27-Residue CCR5 Peptide in a Ternary Complex with HIV-1 gp120 and a CD4-Mimic Peptide
Q35685881	The Effects of the Recombinant CCR5 T4 Lysozyme Fusion Protein on HIV-1 Infection
Q39196591	The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
Q33599835	The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features
Q104111188	The G protein coupled receptor CXCR4 designed by the QTY code becomes more hydrophilic and retains cell signaling activity
Q37045212	The GPCR Network: a large-scale collaboration to determine human GPCR structure and function
Q47780061	The Human Orexin/Hypocretin Receptor Crystal Structures
Q39507478	The Implication of the First Agonist Bound Activated GPCR X-ray Structure on GPCR in Silico Modeling.
Q61811076	The Multitasking Potential of Alarmins and Atypical Chemokines
Q39359407	The N-terminal region of CXCL11 as structural template for CXCR3 molecular recognition: synthesis, conformational analysis, and binding studies
Q30415339	The Protein Structure Initiative: achievements and visions for the future
Q57952195	The Retinitis Pigmentosa-Linked Mutations in Transmembrane Helix 5 of Rhodopsin Disrupt Cellular Trafficking Regardless of Oligomerization State
Q90050404	The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
Q30375950	The Structure of a CXCR4:Chemokine Complex.
Q38077227	The activation of the CGRP receptor
Q24337078	The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization
Q30375598	The development of solid-state NMR of membrane proteins.
Q33799070	The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.
Q34263645	The emerging role of CXC chemokines and their receptors in cancer
Q35655642	The extracellular loops of Smoothened play a regulatory role in control of Hedgehog pathway activation
Q35190517	The identification of high-affinity G protein-coupled receptor ligands from large combinatorial libraries using multicolor quantum dot-labeled cell-based screening
Q35067624	The intricate role of CXCR4 in cancer
Q46810625	The leukotriene B4 receptor BLT1 is stabilized by transmembrane helix capping mutations
Q37609921	The membrane proximal region of the cannabinoid receptor CB1 N-terminus can allosterically modulate ligand affinity
Q39504323	The orexin OX(1) receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands.
Q39642723	The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains
Q36935273	The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization
Q38237899	The receptor concept in 3D: from hypothesis and metaphor to GPCR-ligand structures
Q34090835	The recombinant expression systems for structure determination of eukaryotic membrane proteins
Q34623053	The role of Cysteine 6.47 in class A GPCRs
Q30416991	The role of protein structural analysis in the next generation sequencing era.
Q38089686	The role of the CXCR4 cell surface chemokine receptor in glioma biology
Q37319860	The role of tyrosine sulfation in the dimerization of the CXCR4:SDF-1 complex
Q27315037	The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulations
Q35264433	The significance of G protein-coupled receptor crystallography for drug discovery
Q38151741	The structural role of receptor tyrosine sulfation in chemokine recognition.
Q34057838	The structure of active opsin as a basis for identification of GPCR agonists by dynamic homology modelling and virtual screening assays
Q35425244	The therapeutic potential of orphan GPCRs, GPR35 and GPR55.
Q36439375	The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation
Q33361044	The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes
Q33893103	The use of G-protein coupled receptor models in lead optimization
Q34060799	The yin and yang of chemokine receptor activation
Q45745219	Theoretical characterization of galanin receptor type 3 (Gal3 ) and its interaction with agonist (GALANIN) and antagonists (SNAP 37889 and SNAP 398299): an in silico analysis
Q34179174	Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor
Q41542396	Three "hotspots" important for adenosine A(2B) receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loop
Q27007472	Tools for GPCR drug discovery
Q34611560	Towards improved quality of GPCR models by usage of multiple templates and profile-profile comparison
Q36779515	Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling
Q28082755	Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors
Q38200334	Tuning up the right signal: chemical and genetic approaches to study GPCR functions
Q27024397	Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development
Q34469331	Two disparate ligand-binding sites in the human P2Y1 receptor
Q27667675	Two distinct conformations of helix 6 observed in antagonist-bound structures of a 1-adrenergic receptor
Q35347156	Uncovering the triggers for GPCR activation using solid-state NMR spectroscopy
Q54203381	Understanding GPCR Recognition and Folding from NMR Studies of Fragments.
Q92768615	Understanding Peptide Binding in Class A G Protein-Coupled Receptors
Q26852233	Unlocking the secrets of the gatekeeper: methods for stabilizing and crystallizing GPCRs
Q51015497	Unraveling the structural basis of GPCR activation and inactivation.
Q51715586	Use of Resonance Energy Transfer Techniques for In Vivo Detection of Chemokine Receptor Oligomerization.
Q36332186	Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity
Q90338881	VLA-4 phosphorylation during tumor and immune cell migration relies on its coupling to VEGFR2 and CXCR4 by syndecan-1
Q35966959	Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility
Q55038699	Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy.
Q38680670	What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?
Q33857587	Why is dimerization essential for class-C GPCR function? New insights from mGluR1 crystal structure analysis
Q38093833	X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?
Q44988763	mGluR5: exploration of orthosteric and allosteric ligand binding pockets and their applications to drug discovery
Q53233925	¹³C- and ¹H-detection under fast MAS for the study of poorly available proteins: application to sub-milligram quantities of a 7 trans-membrane protein.
Q34219369	β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma
Q39191447	β2-Adrenergic Receptor Conformational Response to Fusion Protein in the Third Intracellular Loop

P819	ADS bibcode	2010Sci...330.1066W
P356	DOI	10.1126/SCIENCE.1194396
P3181	OpenCitations bibliographic resource ID	499199
P932	PMC publication ID	3074590
P698	PubMed publication ID	20929726
P5875	ResearchGate publication ID	47369849

P50	author	Raymond C. Stevens	Q7298638
		Vsevolod Katritch	Q28317231
		Vadim Cherezov	Q28320126
		Ruben Abagyan	Q44682954
		Tracy M Handel	Q89909578
		Gustavo Fenalti	Q114336928
		Ellen Y T Chien	Q117222588
		Wei Liu	Q124538811
P2093	author name string	Peter Wells
		Alexei Brooun
		Beili Wu
		Clifford D Mol
		Damon J Hamel
		F Christopher Bi
		Peter Kuhn
P2860	cites work	Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants	Q22010387
		HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor	Q22242268
		Involvement of chemokine receptors in breast cancer metastasis	Q24290909
		The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry	Q24315492
		The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist	Q24654563
		High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor	Q24657484
		Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice	Q24681021
		Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants	Q27618367
		Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4	Q27648643
		A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor	Q27650801
		Crystal structure of the ligand-free G-protein-coupled receptor opsin	Q27650885
		Structure of a beta1-adrenergic G-protein-coupled receptor	Q27651011
		Molecular architecture of native HIV-1 gp120 trimers	Q27651385
		Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12	Q27652199
		Crystal structure of opsin in its G-protein-interacting conformation	Q27652301
		Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility	Q27658989
		Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity	Q27660384
		Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor	Q27758437
		Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody	Q27759364
		The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway	Q28145398
		Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development	Q28512895
		The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1	Q29616093
		Chemokines and leukocyte traffic	Q29618886
		Structure of a V3-containing HIV-1 gp120 core	Q29619014
		Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors	Q33377026
		Identification of CXCR4 domains that support coreceptor and chemokine receptor functions	Q33643223
		Increasingly accurate dynamic molecular models of G-protein coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery?	Q33767121
		Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains	Q34045610
		CXCL12 (SDF-1)/CXCR4 pathway in cancer	Q34116260
		Chemokines: immunology's high impact factors	Q34139595
		Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.	Q34447967
		Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists	Q34647172
		CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.	Q34774168
		Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers	Q35594835
		Chemokines: multiple levels of leukocyte migration control.	Q35753105
		The significance of cancer cell expression of the chemokine receptor CXCR4.	Q35832343
		Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling	Q36606981
		Membrane interactive alpha-helices in GPCRs as a novel drug target	Q36683730
		Computational studies of Family A and Family B GPCRs	Q36883937
		Imaging chemokine receptor dimerization with firefly luciferase complementation	Q37123955
		New insights on the role of CXCR4 in cancer metastasis	Q37181856
		Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy	Q37206465
		Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors	Q37208884
		Modulation of chemokine receptor activity through dimerization and crosstalk	Q37355817
		The chemokine receptors CXCR4 and CXCR3 in cancer	Q37393013
		Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.	Q37431503
		Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4.	Q37454403
		A G protein-coupled receptor at work: the rhodopsin model.	Q37616633
		Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding	Q38316857
		Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo	Q39521135
		Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses.	Q39549670
		Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure	Q40020328
		Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation.	Q40024323
		Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.	Q40027201
		Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions	Q40220280
		Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers.	Q40474872
		Structure-activity relationships of chemokines	Q40531026
		Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor	Q40689812
		Selectivity and antagonism of chemokine receptors	Q40943438
		Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles	Q44847236
		Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities	Q45742231
		Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B.	Q45999198
		CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.	Q47975881
		Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers.	Q51795174
		WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12	Q57218463
		T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer	Q73847638
P433	issue	6007
P407	language of work or name	English	Q1860
P921	main subject	G protein-coupled receptor	Q38173
P5008	on focus list of Wikimedia project	ScienceSource	Q55439927
P304	page(s)	1066-71
P577	publication date	2010-11-19
P1433	published in	Science	Q192864
P1476	title	Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists
P478	volume	330

Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists

scientific article

Reverse relations